In-vitro Fertilization and Embryo Transfer (IVF)
In-vitro Fertilization and Embryo Transfer (IVF) is a fertility treatment that involves collecting the eggs from the woman's ovaries, and fertilizing them with the husband's sperms outside the body. The resultant embryo(s) will then be transferred back into the woman's uterus a few days later.
In broad, the process involves:
Medication is used to boost the ovaries to produce more eggs;
A needle is inserted into the ovaries via the vagina to collect the eggs;
The embryo(s) is/are transferred back into the womb.
IVF is used to treat:
Women with blocked or damaged fallopian tubes;
Men with poor semen quality;
Couple with unexplained infertility;
Women with severe endometriosis;
Women in their advanced reproductive age or low ovarian reserve, as time to conception is critical;
Couples with an inherited genetic disease that they wish to avoid passing on to their child, and in this case, IVF is combined with Pre-implantation Genetic Testing (PGT) to select embryos without the disease for transfer.
We work in collaboration with Hong Kong Assisted Reproduction Centre (HKARC) to provide IVF and related treatments. HKARC is an IVF centre specialized in assisted reproduction technology (ART) treatments. Apart from standard IVF treatment, HKARC also provides the full range of advanced ART treatments, including:
Embryoscope time-lapse system;
Pre-implantation genetic testing (PGT), including Pre-implantation Genetic Testing for Aneuploidies (PGT-A), Pre-implantation Genetic Testing – Monogenic Single Gene Disorders (PGT-M) and Pre-implantation Genetic Testing – Structural Chromosomal Rearrangements (PGT-SR);
Embryo freezing by vitrification and embryo storage;
Frozen-thawed embryo transfer.